Another study proposed that mechanisms of quercetin in treating colon cancer may involve inhibition of the TLR4/NF-κB signaling pathway as well as the reduction in the production of inflammation factors, including TNF-α, Cox-2, and IL-6 [53]. Here, NFKB1 is linked to malignant colon neoplasm.